Back to company

UNIPHARMA ApS: Financial statements 2022

CVR: 78881917

UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 0 and a net result of DKK -88 compared with DKK -5,190 the year before. Equity amounted to DKK 56,457. The solvency ratio was 31.3%.

Revenue
0 kr.
Gross Profit
0 kr.
Profit/Loss
-88 kr.
Equity
56,457 kr.
Total Assets
180,502 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202200-8856 t.-
2021---5 t.57 t.-
2020-5 t.-5 t.-5 t.62 t.-
2019-5 t.-5 t.-5 t.67 t.-
2018-10 t.-10 t.-10 t.72 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on UNIPHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

UNIPHARMA ApS: The 2021 annual report is outJun 29, 2022

UNIPHARMA ApS has published its annual report for 2021. The net result was DKK -5,190.

About UNIPHARMA ApS

UNIPHARMA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert and Ebba Dorrit Reumert. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK -124,033.